Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy

ClinicalTrials.gov ID: NCT04794491

Public ClinicalTrials.gov record NCT04794491. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 8:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4 Multicenter, Open-label, Single-arm Study of Safety, Tolerability, Effectiveness and Treatment Optimization in Participants Switching From Xyrem to XYWAV for the Treatment of Narcolepsy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The rationale for the interventional, open-label, single-arm design of JZP258-401 is to evaluate the clinical experience in participants with narcolepsy transitioning treatment from Xyrem to XYWAV.

Study identification

NCT ID
NCT04794491
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
62 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 22, 2021 (Actual)
Primary completion
Nov 15, 2022 (Actual)
Completion
Nov 15, 2022 (Actual)
Last update posted
Jan 9, 2024

2021 – 2022

United States locations

U.S. sites
28
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Wright Clinical Research, LLC Alabaster Alabama 35007 —
Sleep Disorders Center of Alabama Birmingham Alabama 35213 —
Pulmonary Associates of the Southeast, PC Birmingham Alabama 35254 —
Santa Monica Clinical Trials Los Angeles California 90025 —
Southern California Institute For Respiratory Diseases, Inc./ Tower Sleep Medicine Los Angeles California 90048 —
Southern California Institute For Respiratory Diseases, Inc. Los Angeles California 90048 —
Stanford University- Sleep Medicine Redwood City California 94063 —
SDS Clinical Trials, Inc Santa Ana California 92705 —
Delta Waves, Inc. Colorado Springs Colorado 80918 —
Pulmonary Disease Specialists, PA d/b/a PDS Research Kissimmee Florida 34741 —
Clinical Research of West Florida, Inc Tampa Florida 33606 —
Florida Pediatric Research Institute, LLC Winter Park Florida 32789 —
Sleep Practitioners LLC Macon Georgia 31210 —
Clinical Research Institute Stockbridge Georgia 30281 —
The Center for Sleep & Wake Disorders Chevy Chase Maryland 20815 —
WMed Center for Clinical Research Kalamazoo Michigan 49008 —
Minnesota Lung Center Edina Minnesota 55435 —
Clayton Sleep Institute, LLC St Louis Missouri 63123 —
Clinical Research of Gastonia Gastonia North Carolina 28054 —
Intrepid Research LLC Cincinnati Ohio 45245 —
Cleveland Clinic, Sleep Disorders Center Cleveland Ohio 44195 —
Ohio Sleep Medicine Institute Dublin Ohio 43017 —
Geisinger Clinic Danville Pennsylvania 17822 —
Bogan Sleep Consultants, LLC Columbia South Carolina 29201 —
Medical University of South Carolina, Department of Psychiatry and Behavioral Sciences North Charleston South Carolina 29425 —
Clinical Research of Rock Hill Rock Hill South Carolina 29732 —
FutureSearch Trials of Neurology Austin Texas 78731 —
Sleep Therapy & Research Center San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04794491, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 9, 2024 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04794491 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →